Chondroprotective/restorative compositions and methods of use thereof
First Claim
1. A method of treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, the reduction or inhibition of the production of Hyaluronic acid in a mammal, said method comprising orally administering to said mammal a therapeutically effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
The instant invention provides a method of treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function including joint mobility, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, the reduction or inhibition of the production of Hyaluronic acid, said method comprising orally administering to a mammalian species a therapeutically effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof. Additionally, compositions containing hyaluronic acid; chondroitin sulfate, and glucosamine sulfate in a paste formulation are also disclosed which can be administered on their own or can be used as a feed additive.
76 Citations
38 Claims
- 1. A method of treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, the reduction or inhibition of the production of Hyaluronic acid in a mammal, said method comprising orally administering to said mammal a therapeutically effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof.
- 10. A Chondroprotective/Restorative composition comprising an effective amount Hyaluronic Acid or its pharmaceutically acceptable salts and optionally a pharmaceutically acceptable carrier.
-
11. A Chondroprotective/Restorative composition comprising:
-
(a) an effective amount of Glucosamine sulfate;
(b) an effective amount Hyaluronic Acid or pharmaceutically acceptable salts thereof; and
(c) optionally a pharmaceutically acceptable carrier. - View Dependent Claims (15, 16, 17, 19, 20, 21, 22, 23, 24, 25, 26, 28, 30, 31, 32, 33, 34, 36, 37, 38)
-
-
12. A Chondroprotective/Restorative composition comprising:
-
(b) an effective amount of Chondroitin sulfate;
(b) an effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof; and
(c) optionally a pharmaceutically acceptable carrier.
-
-
13. A Chondroprotective/Restorative composition comprising
(a) an effective amount of Glucosamine sulfate; -
(b) an effective amount of Chondroitin sulfate;
(c) an effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof; and
(d) optionally a pharmaceutically acceptable carrier.
-
-
18. An animal feed having Chondroprotective/Restorative benefits comprising:
-
(a) a nutritionally effective feed base selected from the group consisting of grains, proteins, fats and mixtures thereof; and
(b) an effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof.
-
-
27. A therapeutic and Chondroprotective/Restorative composition comprising:
-
(a) an effective amount of hyaluronic Acid or its pharmaceutically acceptable salts;
(b) an effective amount of a therapeutic drug; and
(c) optionally a pharmaceutically acceptable carrier.
-
-
29. A Chondroprotective/Restorative composition in paste form comprising:
-
(a) an effective amount of Hyaluronic Acid or its pharmaceutically acceptable salts; and
(b) a sufficient amount of molasses to make a paste.
-
-
35. A Chondroprotective/Restorative composition in gel form comprising:
-
(a) an effective amount of Hyaluronic Acid or its pharmaceutically acceptable salts;
(b) water; and
(c) a sufficient amount of carboxymethylcellulose or its sodium salt to make a gel.
-
Specification